Press Releases

Media Focus

The Right Partner to Advance Your Molecule From Gene to Commercialization

MEDIA FOCUS 

MEDIA FOCUS

The Right Partner to Advance Your Molecule From Gene to Commercialization

Daniel Buckley

Lead Scientist in CDO Downstream

 

From gene to commercialization, working with a #CDMO partner is an advantage when it comes to moving your product to market without delay. In the latest PharmTech Podcast episode, Daniel Buckley, our Lead Scientist in CDO Downstream, talks about the common challenges in the drug development process and how we are addressing these challenges through a robust platform approach and end-to-end services at a single site. 


Go to podcast

MEDIA FOCUS 

MEDIA FOCUS

The Right Partner to Advance Your Molecule From Gene to Commercialization

Daniel Buckley

Lead Scientist in CDO Downstream

 

From gene to commercialization, working with a #CDMO partner is an advantage when it comes to moving your product to market without delay. In the latest PharmTech Podcast episode, Daniel Buckley, our Lead Scientist in CDO Downstream, talks about the common challenges in the drug development process and how we are addressing these challenges through a robust platform approach and end-to-end services at a single site. 


Go to podcast

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION